| GSRX Industries (OTCQB: GSRX) to Launch Pure and Natural CBD Line with Grammy Award Winner Matt Sorum |
| |
|
GSRX Industries (OTCQB: GSRX) announced last week that its Pure and Natural LLC subsidiary signed an agreement with Rock & Roll Hall of Fame Inductee and Grammy Award winner Matt Sorum to develop, market and distribute a new line of pure, full-spectrum, hemp-based, non-THC CBD products branded In The Zone by Matt Sorum.
Why It Matters: Matt Sorum is a legendary rock drummer who has played all over the world as a member of Guns N’ Roses, the supergroup Velvet Revolver, Kings of Chaos, the Cult, and now his new rock unit Deadland Ritual. He has released two solo albums – Hollywood Zen and Stratosphere. Matt is very involved in technology as a partner in Sthorm, that announced ARTBIT at SXSW last year, a distributed-ledger platform that enables artists and fans to share and monetize through a token economy from anywhere in the world. Sthorm has three more startups coming in 2020. Matt is Co-founder of Adopt the Arts, a 501c3 Non-profit whose mission it is to keep Art and Music in public schools.
Key Quote: “This new partnership is something that I am really excited about. As a longtime user and fan of CBD, I can’t wait to introduce my own proprietary line of safe and effective CBD products to people everywhere. And I am really happy to be partnering on In The Zone with longtime friend Christian Briggs and his great team.” Matt Sorum
Disclosure
GSRX Industries (OTCQB: GSRX) is a client of RedChip Companies. RedChip Companies, Inc. received 1,000,000 registered shares of GSRX for consulting services. Be advised RedChip intends to sell some or all of its shares at any time, including when you are buying.
|
|
| |
|
| Level Brands’ (NYSE American: LEVB) cbdMD Launches Highly Anticipated CBD Sleep Aid |
| |
|
cbdMD, a Level Brands company (NYSE American: LEVB), officially launched their CBD sleep aid, CBD PM, on Daylight Savings, just in time for World Sleep Day (March 15).
Why It Matters: It’s estimated that 70 million people in the U.S. suffer from some form of sleeplessness. cbdMD presents a natural, non-habit-forming alternative. Working with the body’s endocannabinoid system (ESC) – which helps to regulate vital, internal functions – CBD promotes recovery and overall wellness; that combined with the powerful benefits of melatonin, offer a solution for a restful night’s sleep.
Key Quote: “Analyzing the numbers, its staggering how many people struggle with sleep on a regular basis. Our CBD PM sleep aid promotes relaxation throughout the night, allowing you to – Sleep Naturally. Wake Refreshed.” – Caryn Dunayer, President of cbdMD
Disclosure
Level Brands (NYSE American: LEVB) is a client of RedChip Companies. LEVB agreed to pay RedChip a monthly cash fee and 5,000 shares of Rule 144 stock for four months of RedChip investor awareness services.
|
|
| |
|
| MYnd Analytics (NASDAQ: MYND) Joins Magellan Healthcare Provider Network to Offer Telebehavioral Health Services |
| |
|
MYnd Analytics (NASDAQ: MYND), a predictive analytics company aimed at improving the delivery of mental health through the combination of telemedicine and data analytics, announced that its wholly owned subsidiary, Arcadian Telepsychiatry Services LLC, has joined the Magellan Healthcare behavioral health provider network to offer telepsychiatry, teletherapy and teleEAP services to its members through Arcadian’s provider network.
Key Quote: “We are honored to collaborate with Magellan to offer our telepsychiatry, teletherapy and teleEAP services to their members. Magellan’s members now have access to telebehavioral health services from the comfort and convenience of their home using web-enabled video conferencing,” said Patrick Herguth, CEO of MYnd Analytics
The Backstory: MYnd Analytics (NASDAQ: MYND) is a predictive analytics company that has developed a decision support tool to help physicians reduce trial and error treatment in mental health and provide more personalized care to patients. The Company’s Psychiatric EEG Evaluation Registry, or PEER Online, is a registry and reporting platform that allows medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through a standard electroencephalogram (EEG). Based on the Company’s original physician-developed database, there are now more than 40,000 outcomes for over 11,000 unique patients in the PEER registry. The goal of PEER Online is to provide objective, personalized data to assist physicians in the selection of appropriate medications. To read more about the benefits of this patented technology for patients, physicians and payers, please visit:
www.myndanalytics.com.
Disclosure
MYnd Analytics (NASDAQ: MYND) is a client of RedChip Companies, Inc. MYND agreed to pay RedChip Companies, Inc. a monthly cash fee for RedChip investor awareness services.
|
|
| |
|
| eMARINE Global (OTC: EMRN) Announces Contract to Supply its Warship-ECDIS for 20 Republic of Korea Navy Vessels |
| |
|
eMARINE Global (OTC: EMRN), a leading provider of information and communications technology (ICT) for the maritime industry, was awarded a contract to supply its Warship-ECDIS (Electronic Chart Display & Information System) for 20 Republic of Korea Navy vessels. The contract is valued at 500 million Won ($500,000).
Key Quote: “As a critical component of smart ship solutions, our customers’ commitment to ongoing work, as evidenced by this latest award, is a strong testament to the industry-leading quality and positioning of our growing suite of information and communications technology (ICT) solutions.” – Ung Gyu Kim, Chairman and CEO of eMARINE Global
What’s Next: Founded in 2001 and based in South Korea, eMARINE Global is working with a growing base of marquee customers to achieve maritime ICT convergence through fully integrated products and services, offering state-of-the-art e-navigation, marine Internet of Things (IoT), and marine big data solutions, primarily in Korea with near-term expansion into U.S. and Chinese markets. eMARINE Global’s customer base includes Hyundai Heavy Industries, Samsung Heavy Industries, and SAAB.
Disclosure
eMARINE Global (OTC: EMRN) is a client of RedChip Companies. RedChip Companies, Inc. owns 613,000 shares of EMRN common stock.
|
|
| |
|
| Nemaura Medical (NASDAQ: NMRD) Announces Exclusive License and Supply Agreement for SugarBEAT® in the GCC Region |
| |
|
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by diabetics and pre-diabetics, today announced that it has signed an exclusive license and supply agreement for SugarBEAT® with TPMENA in the Gulf Cooperation Council (GCC) Region, which includes Bahrain, Kuwait, Saudi Arabia, Oman and United Arab Emirates.
Why It Matters: TPMENA is a distributor of medical devices in the GCC Region, backed by Cigalah group (naghi-group.com). TPMENA is headquartered in Saudi Arabia, which markets and sells many of the leading brands of medicines and medical devices. The GCC Region has more than 35 million diabetics, with data from the International Diabetes Federation showing prevalence of the disease has reached 23.9% of the adult population in Saudi Arabia and 23.1% in Kuwait, which is more than twice the global average of 8.3%.
Key Quote: “The GCC Region is a key market for SugarBEAT® because the prevalence of diabetes is one of the highest in the world. We are delighted to be involved with TPMENA, which brings an extensive network and proven track record. Over the past year, we have established a strong relationship with senior management of TPMENA and have full confidence that TPMENA is an exceptional partner for SugarBEAT®. Prior to entering into the agreement, TPMENA conducted extensive market research, with very positive feedback from both consumers and key opinion leaders. We look forward to accelerating the registration processes required for an aggressive GCC commercial launch of SugarBEAT® upon receipt of CE Mark approval.” – Dr. Faz Chowdhury, CEO of Nemaura Medical
Disclosure
Nemaura Medical (NASDAQ: NMRD) is a client of RedChip Companies. NMRD agreed to pay RedChip a monthly cash fee for investor awareness services.
|
|
| |
|
| Cuentas (OTCQB: CUEN) Signs LOI for Innovative AI and Big Data Tech for Digital Banking and Mobile Payment Services |
| |
|
Cuentas (OTCQB: CUEN), one of the most promising players in the mobile banking and digital payments market, signed a Letter of Intent (LOI) with Facio Ltd, an Israel financial technology (FinTech) company that has developed innovative artificial intelligence and big data technologies to deliver digital banking services autonomously, without human intervention.
Why It Matters: Cuentas will become the first digital partner to operate autonomously while maintaining its operational team and IT department with minimal personnel. This, of course, translates to savings in financial services and enhancement of personalized customer experience.
Key Quote: “We are extremely pleased to work together with Facio to develop new capabilities never seen in mobile payment and online banking applications. The potential to combine our mobile wallet with Artificial Intelligence and Data mining should provide for better consumer experiences and more efficient operations.” – Arik Maimon, CEO of Cuentas
Disclosure
Cuentas (OTCQB: CUEN) agreed to pay RedChip Companies, Inc. 10,000 shares of Rule 144 stock and a monthly cash fee for three (3) months of investor relation awareness services.
|
|
| |
|
| Catasys (NASDAQ: CATS) Reported Record Revenue of $5.6 Million in Q4 2018, up 85.3% Year over Year and up 28.7% from Q3 2018 |
| |
|
- YE 2018 record revenue of $15.2 million, up 96.7% from YE 2017
- Outreach pool of eligible members increased to approximately 75,000 Members at March 1, 2019 (up 97% from 38,000 at Q3 2018) as a result of significant expansion within existing plans
- Reiterates 2019 GAAP revenue guidance of $35 million
Key Quote: “Catasys has had a strong start to 2019, as continued expansions with existing health plan partners significantly accelerated our outreach pool of eligible members to record levels. The signing of contracts with new health plans, launches in new states, and program expansions led to solid enrollment growth for the Company in 2018. We are reiterating our previous guidance of $35 million of revenues for 2019,” said Mr. Terren Peizer, Chairman and CEO of Catasys
2019 Guidance
- Catasys (NASDAQ: CATS) expects to report revenues of at least $35 million in 2019. The Company anticipates that this revenue increase will be supported through accelerating enrollment growth during the remainder of this year, with the largest portion of the revenue increase to occur in the second half of 2019.
- This guidance solely represents existing enrollment launches with current health plan partners and program expansions with existing customers
- Annual guidance does not include new contracts and subsequent launches, initial launches of existing contracts, and new expansions within existing contracts that may increase its outreach pool throughout the year. As a result of these subsequent developments, the Company may revise guidance at that time.
The Backstory: Catasys, Inc. harnesses proprietary big data predictive analytics, artificial intelligence and telehealth, combined with human intervention, to deliver improved member health and cost savings to health plans through integrated technology enabled treatment solutions. It is our mission to provide access to affordable and effective care, thereby improving health and reducing cost of care for people who suffer from the medical consequences of behavioral health conditions; helping these people and their families achieve and maintain better lives.
Disclosure
Catasys (NASDAQ: CATS) is a client of RedChip Companies, Inc. CATS agreed to pay RedChip Companies, Inc. a monthly cash fee for RedChip investor awareness services and consulting services.
|
|
| |
|
| Small Caps Outperforming in 2019 |
| |
|
Through March 1, the small-cap Russell 2000 index had returned more than 18%, versus about 12% for the large-cap S&P 500. In the first two weeks of March, large cap gains have moved toward closing the performance gap, with the S&P 500 gaining another 0.5% while the Russell has declined around 2%.
“Small-caps remain a very key component of the market’s comeback story,” wrote Instinet Executive Director Frank Cappelleri to clients earlier this month. “Seeing demand reignite in the most speculative names would give us a strong indication that the bid can continue. And vice versa.”
|
|
| |
|
| |
| Quote of the Week |
| |
"Microcaps are a three card monte play. If you don't know how to play, stay away"
- Greg Sichenzia, Founding Partner, Sichenzia Ross Friedman Ference LLP |
|
|
|
|
|
|
|
| About RedChip |
| |
| RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. |
| |
| RedChip Disclosure |
| |
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures. |
|
| |
|
|
| |
|
Copyright © 2019 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.
If you received this email by mistake you can unsubscribe from all emails.
|
|
|
|
|
|
